Admission Glucose Level and Short-term Mortality in Older Patients with Acute Myocardial Infarction: Results from the KORA Myocardial Infarction Registry

Overview

Journal BMJ Open

Specialty General Medicine

Date 2021 Jun 4

PMID 34083341

Citations 4

Authors

Temur Mamadjanov

Konstantinos Volaklis

Margit Heier

Dennis Freuer

Ute Amann

Annette Peters

B Kuch

Christian Thilo

Jakob Linseisen

Christa Meisinger

Affiliations

Soon will be listed here.

Abstract

Study Objectives: To investigate the association between admission blood glucose levels and 28-day mortality as well as in-hospital complications in older patients with incident acute myocardial infarction (AMI) undergoing modern treatment.

Methods: From a German population-based regional MI registry, 5530 patients (2016 women), aged 65-84 years, hospitalised with an incident AMI between 1 January 2009 and 31 December 2016 were included in the study. Multivariable logistic regression models were used to assess the associations between admission blood glucose and 28-day mortality as well as in-hospital complications after AMI. Analyses stratified according to age, diabetes and type of infarction (ST-elevation MI (STEMI)/non-STEMI) were conducted.

Results: The adjusted ORs for the association between admission blood glucose and 28-day mortality in young-old (65-74 years) and old (75-84 years) patients with AMI were 1.40 (95% CI: 1.21 to 1.62) and 1.21 (95% CI: 0.98 to 1.50) per 1 SD increase in admission blood glucose, respectively. Furthermore, higher admission blood glucose was related to case fatality irrespective of the diabetes status and type of infarction only in the under-75 group. For the patients aged 75-84 years, it was only true for those without diabetes and STEMI. Admission blood glucose was also associated with major cardiac complications in both age groups.

Conclusion: Admission blood glucose was significantly associated with 28-day case fatality in patients with AMI aged 65-74 years but not 75-84 years; furthermore, in both age groups there was an increased risk of major complications. It seems that admission glucose may play a rather minor role in terms of case fatality in higher aged patients with AMI.

Citing Articles

Impact of admission glucose and 30-day major adverse cardiovascular events on patients with chest pain in an emergency setting: insights from the China EMPACT registry.

Yin X, Pan X, Zhang J, Wu S, Cui W, Wang Y Front Cardiovasc Med. 2024; 11:1367704.

PMID: 39444552 PMC: 11496057. DOI: 10.3389/fcvm.2024.1367704.

Longitudinal trajectories of blood glucose and 30-day mortality in patients with diabetes mellitus combined with acute myocardial infarction: A retrospective cohort analysis of the MIMIC database.

Deng B, Liu Q, Qiao L, Lv S PLoS One. 2024; 19(9):e0307905.

PMID: 39269943 PMC: 11398677. DOI: 10.1371/journal.pone.0307905.

A systematic review and meta-analysis of the effect of hyperglycemia on admission for acute myocardial infarction in diabetic and non-diabetic patients.

Alawaji R, Musslem M, Alshalahi E, Alanzan A, Sufyani A, Alhati M Diabetol Metab Syndr. 2024; 16(1):224.

PMID: 39267155 PMC: 11391676. DOI: 10.1186/s13098-024-01459-w.

Association between psoriasis and short-term outcomes of acute myocardial infarction: A matched-pair cohort study using a nationwide inpatient database in Japan.

Miyachi H, Konishi T, Shigemi D, Matsui H, Shimizu S, Fushimi K JAAD Int. 2022; 8:21-30.

PMID: 35620322 PMC: 9127561. DOI: 10.1016/j.jdin.2022.04.007.

References

Hadjadj S, Coisne D, Mauco G, Ragot S, Duengler F, Sosner P . Prognostic value of admission plasma glucose and HbA in acute myocardial infarction. Diabet Med. 2004; 21(4):305-10. DOI: 10.1111/j.1464-5491.2004.01112.x. View

Ishihara M . Acute hyperglycemia in patients with acute myocardial infarction. Circ J. 2012; 76(3):563-71. DOI: 10.1253/circj.cj-11-1376. View

Chang J, Zhang G, Zhang L, Hou Y, Liu X, Zhang L . High admission glucose levels increase Fas apoptosis and mortality in patients with acute ST-elevation myocardial infarction: a prospective cohort study. Cardiovasc Diabetol. 2013; 12:171. PMC: 3842819. DOI: 10.1186/1475-2840-12-171. View

Goyal A, Mahaffey K, Garg J, Nicolau J, Hochman J, Weaver W . Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study. Eur Heart J. 2006; 27(11):1289-97. DOI: 10.1093/eurheartj/ehi884. View

Foo K, Cooper J, Deaner A, Knight C, Suliman A, Ranjadayalan K . A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes. Heart. 2003; 89(5):512-6. PMC: 1767629. DOI: 10.1136/heart.89.5.512. View

Cheng H, Yen P . Killip classification and glucose level in patients with acute myocardial infarction. Am J Emerg Med. 2010; 28(8):853-6. DOI: 10.1016/j.ajem.2009.04.029. View

Chattopadhyay S, George A, John J, Sathyapalan T . Two-hour post-challenge glucose is a better predictor of adverse outcome after myocardial infarction than fasting or admission glucose in patients without diabetes. Acta Diabetol. 2018; 55(5):449-458. DOI: 10.1007/s00592-018-1114-2. View

Otten A, Ottervanger J, Timmer J, van t Hof A, Dambrink J, Gosselink A . Age-dependent differences in diabetes and acute hyperglycemia between men and women with ST-elevation myocardial infarction: a cohort study. Diabetol Metab Syndr. 2013; 5(1):34. PMC: 3710249. DOI: 10.1186/1758-5996-5-34. View

Li D, Hua Q, Guo J, Li H, Chen H, Zhao S . Admission glucose level and in-hospital outcomes in diabetic and non-diabetic patients with ST-elevation acute myocardial infarction. Intern Med. 2011; 50(21):2471-5. DOI: 10.2169/internalmedicine.50.5750. View

10.

Stranders I, Diamant M, van Gelder R, Spruijt H, Twisk J, Heine R . Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med. 2004; 164(9):982-8. DOI: 10.1001/archinte.164.9.982. View

11.

Kim E, Jeong M, Kim J, Ahn T, Seung K, Oh D . Clinical impact of admission hyperglycemia on in-hospital mortality in acute myocardial infarction patients. Int J Cardiol. 2017; 236:9-15. DOI: 10.1016/j.ijcard.2017.01.095. View

12.

Bellodi G, Manicardi V, Malavasi V, Veneri L, Bernini G, Bossini P . Hyperglycemia and prognosis of acute myocardial infarction in patients without diabetes mellitus. Am J Cardiol. 1989; 64(14):885-8. DOI: 10.1016/0002-9149(89)90836-9. View

13.

Timmer J, Hoekstra M, Nijsten M, van der Horst I, Ottervanger J, Slingerland R . Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segment-elevation myocardial infarction treated with percutaneous coronary intervention. Circulation. 2011; 124(6):704-11. DOI: 10.1161/CIRCULATIONAHA.110.985911. View

14.

Meisinger C, Hormann A, Heier M, Kuch B, Lowel H . Admission blood glucose and adverse outcomes in non-diabetic patients with myocardial infarction in the reperfusion era. Int J Cardiol. 2005; 113(2):229-35. DOI: 10.1016/j.ijcard.2005.11.018. View

15.

Timmer J, van der Horst I, Ottervanger J, Henriques J, Hoorntje J, de Boer M . Prognostic value of admission glucose in non-diabetic patients with myocardial infarction. Am Heart J. 2004; 148(3):399-404. DOI: 10.1016/j.ahj.2004.04.007. View

16.

Capes S, Hunt D, Malmberg K, Gerstein H . Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000; 355(9206):773-8. DOI: 10.1016/S0140-6736(99)08415-9. View

17.

Hsu C, Chen H, Sheu W, Chu S, Shen Y, Wu C . Initial serum glucose level as a prognostic factor in the first acute myocardial infarction. Ann Emerg Med. 2006; 49(5):618-26. DOI: 10.1016/j.annemergmed.2006.10.023. View

18.

Hao Y, Lu Q, Li T, Yang G, Hu P, Ma A . Admission hyperglycemia and adverse outcomes in diabetic and non-diabetic patients with non-ST-elevation myocardial infarction undergoing percutaneous coronary intervention. BMC Cardiovasc Disord. 2017; 17(1):6. PMC: 5217588. DOI: 10.1186/s12872-016-0441-x. View

19.

Marfella R, Siniscalchi M, Esposito K, Sellitto A, De Fanis U, Romano C . Effects of stress hyperglycemia on acute myocardial infarction: role of inflammatory immune process in functional cardiac outcome. Diabetes Care. 2003; 26(11):3129-35. DOI: 10.2337/diacare.26.11.3129. View

20.

Kosiborod M, Inzucchi S, Krumholz H, Xiao L, Jones P, Fiske S . Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation. 2008; 117(8):1018-27. DOI: 10.1161/CIRCULATIONAHA.107.740498. View